Advanced Practice Strategies, Inc. Adds Summation Health Ventures as Investor

Advanced Practice Strategies, Inc. (APS), provider of an e-learning and talent management platform for clinicians, announced today that Summation Health Ventures (SHV) has joined River Cities Capital Funds and Ascension Ventures in a private investment in APS. SHV is a strategic health care investment fund that aims to accelerate entrepreneurial solutions for the nation’s health care systems, and is backed by the expertise of two renowned health system providers — MemorialCare Health System and Cedars-Sinai Health System.

“APS has developed solutions that drive the operating performance of health systems, particularly their clinical performance,” says Brant Heise, Senior Managing Director at SHV, who joins APS as a board observer. “Our health system partners clearly see the value of APS and want to be part of scaling APS solutions into other top health systems.”

“It is great to have health system investors validate the ROI of our solutions,” says Russell Richmond, MD, CEO of APS. “The addition of SHV to our investor group will help APS focus on the most important needs of these systems. We’re excited to have SHV join River Cities Capital Funds and Ascension Ventures to accelerate the growth of the company.”

About Advanced Practice Strategies (APS)
Advanced Practice Strategies (APS) is a software platform company committed to helping every clinician reach their highest potential. The platform, GNOSIS, engages physicians, nurses and other clinicians through a first-of-its-kind assessment that measures clinical knowledge and judgment and then deploys an individualized Learning Path. The Learning Path delivers prioritized content, targeting each clinician’s specific needs. GNOSIS then uses the data from the over 30,000 assessments completed to provide actionable insight into high risk areas across multiple levels of care. For more information regarding APS, please visit

About Summation Health Ventures
Summation Health Ventures provides strategic investment funding to privately held companies offering innovative products, services, and technologies, which help health care systems significantly improve performance and outcomes.